Genexine Inc (095700) — Cash Flow Reinvestment Rate

Latest as of March 2025: 9.89x

Genexine Inc (095700) has a Cash Flow Reinvestment Rate of 9.89x as of March 2025, reinvesting ₩7.91 Billion (capex ₩3.89 Billion plus investments ₩-4.01 Billion) from operating cash flow of ₩799.82 Million. Check 095700 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

9.89x
(Capex + Investments) / Operating CF

Total Reinvested

₩7.91 Billion
Capex + Investments

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Genexine Inc Cash Flow Reinvestment Rate (2009–2012)

Historical reinvestment intensity for Genexine Inc across 2 annual periods. Explore 095700 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Genexine Inc (2009–2012)

Year-by-year capital reinvestment analysis for Genexine Inc. For live market cap and broader valuation context, see 095700 stock market capitalisation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2012 12.61x ₩21.04 Billion ₩1.67 Billion ₩2.42 Billion ▼ -98.2%
2009 683.23x ₩24.07 Billion ₩35.23 Million ₩1.03 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow